Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

It might sound basic, but data shows that focusing on healthy food and structured exercise might help patients with cancer live longer or respond to therapy. Other cancer news reports on immunotherapy ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

According to a McKinsey analysis, women spend 25% more time than men in poor health — and investments addressing the women’s ...

Hot flashes are sudden surges of sweat, sudden heat, or flushed skin. They are a common symptom of menopause. According to J ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

Discover how scientists can delay menopause by 10+ years using rapamycin and tissue preservation. Revolutionary options.

Wondering if Provitalize works for menopause symptoms? Read our honest Provitalize reviews, ingredient analysis, side effects ...

Hot flashes are most commonly caused by hormone changes related to menopause, Thurston explains. Specifically, the rapid drops of reproductive hormones such as estrogen and progesterone impact the ...